C4 Therapeutics, Inc. - Common Stock (NQ:CCCC)

2.950 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about C4 Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 13, 2023

Via Benzinga

Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet ↗

December 13, 2023

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

C4 Therapeutics Inc. (NASDAQ: CCCC) is One of Wednesday Morning’s Most Active Stocks

December 13, 2023

Via Investor Brand Network

US Stocks Mixed; Producer Prices Unchanged For November ↗

December 13, 2023

U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to...

Via Benzinga

Topics Stocks

C4 Therapeutics Stock Is Surging Wednesday: What's Going On? ↗

December 13, 2023

C4 Therapeutics Inc (NASDAQ: CCCC) shares are trading higher Wednesday after the company presented data from a Phase 1 trial for the p

Via Benzinga

Expert Ratings for C4 Therapeutics ↗

November 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 13, 2023

Via Benzinga

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 13, 2023

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape...

Via Benzinga

D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 13, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 13, 2023

Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!

Via InvestorPlace

C4 Therapeutics Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma

December 12, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

Crude Oil Down 4%; Aditxt Shares Spike Higher ↗

December 12, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday. The Dow traded up 0.32% to 36,520.57 while the NASDAQ rose 0.46% to 14,498.23. The S&P...

Via Benzinga

Topics Stocks

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 12, 2023

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 12, 2023

Via Benzinga

Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results ↗

December 12, 2023

U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.35% to 36,533.63 while the NASDAQ rose 0.16% to 14,455.15 The S&P...

Via Benzinga

Topics Stocks

Why Is Aditxt (ADTX) Stock Up 58% Today? ↗

December 12, 2023

Aditxt stock is up on Tuesday as investors in ADTX shares react to the company announcing plans to acquire Evofem Biosciences.

Via InvestorPlace

EGLE Stock Pops as Star Bulk Buys Eagle Bulk for $500 Million ↗

December 12, 2023

Eagle Bulk Shipping stock is climbing higher on Tuesday after EGLE investors learned of a merger agreement with Star Bulk Carriers.

Via InvestorPlace

Why Is C4 Therapeutics (CCCC) Stock Up 72% Today? ↗

December 12, 2023

C4 Therapeutics stock is rising higher on Tuesday as investors in CCCC shares celebrate a new collaboration agreement with Merck.

Via InvestorPlace

US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November ↗

December 12, 2023

U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 36,389.01 while the NASDAQ fell...

Via Benzinga

Topics Economy Stocks

Why Is Cancer-Focused C4 Therapeutics Stock Soaring Today? ↗

December 12, 2023

C4 Therapeutics Inc (NASDAQ: CCCC) has entered into an exclusive license and collaboration agreement with Merck & Co Inc (NYSE: MRK) to develop degrader-antibody conjugates (DACs), an emerging modality...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 12, 2023

Via Benzinga

C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degrader-Antibody Conjugates (DACs)

December 12, 2023

Initial Focus on One Oncology Target, Exclusive to Collaboration; Merck has Option for Three Additional Targets

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics to Host Webcast to Present New Dose Escalation Data from CFT7455 Phase 1 Study in Relapsed/Refractory Multiple Myeloma

November 28, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment

November 20, 2023

Owen Hughes, Accomplished Life Sciences Executive with Deep Experience Across Investing, Operations and Governance, Appointed as Independent Member of the Board of Directors

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

November 01, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 23, 2023

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 23, 2023

Via Benzinga

C4 Therapeutics Announces Upcoming Data Presentations for CFT8634, an Orally Bioavailable BiDAC™ Degrader in Development for Synovial Sarcoma and SMARCB1-Null Tumors, and CFT7455, an Orally Bioavailable MonoDAC™ Degrader in Development for Multiple

October 11, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Announces Chief Financial Officer Succession

September 05, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

August 08, 2023

From C4 Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.